BRIAN MOHLER: Open Payments
NPI 1609630698 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 71 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,632 · 2025 $1,360
Food & beverage: $1,360
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $225 |
| ABBVIE INC. | 11 | $220 |
| Phathom Pharmaceuticals, Inc. | 6 | $111 |
| Esperion Therapeutics, Inc. | 4 | $86 |
| PFIZER INC. | 4 | $80 |
| Lilly USA, LLC | 4 | $76 |
| Astellas Pharma US Inc | 4 | $73 |
| Amgen Inc. | 4 | $68 |
| Exact Sciences Corporation | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
Products named: VRAYLAR, VOQUEZNA, NEXLETOL, Ozempic, Veozah, PREVNAR 20, The Cologuard Plus Collection Kit, Kerendia.
Industry payments across FL — which companies pay providers there.
